US Drug Recall Register
Class III · Low risk Terminated Initiated Jun 4, 2020 (6 years ago)

Brimonidine Tartrate Opthalmic Solution 0.2%

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Failed Impurities/Degradation Specification: There is a slow leaching process from the product label on the bottle which may impact the product over the shelf life.

What was recalled

Brimonidine Tartrate Opthalmic Solution 0.2%, 5 mL bottle, Rx only, Manufactured for: Somerset Therapeutics, LLC Hollywood, FL 33024. Made in India. NDC 70069-231-01

Recalling firm
Somerset Therapeutics LLC
NDC code
70069-231-01
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1373-2020

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Brimonidine recalls

See all
Class II · Moderate risk Completed

Brimonidine Tartrate Ophthalmic Solution 0.15%

Reason Lack of sterility assurance: Cracks have developed in some of the units caps of Brimonidine tartrate ophthalmic solution bottles. There is a possibility the broken cap may impact sterility.

Apotex Corp. NDC 60505-0564-1 D-0433-2023
Class III · Low risk Terminated

Brimonidine Tartrate Opthalmic Solution 0.2%

Reason Failed Impurities/Degradation Specification: There is a slow leaching process from the product label on the bottle which may impact the product over the shelf life.

Somerset Therapeutics LLC NDC 70069-233-01 D-1375-2020